The Russian company Renewal will start producing L-thyroxine, which is used to treat thyroid diseases. In early March, due to increased demand, a vital drug disappeared from pharmacies in a number of regions
Photo: Evgeny Odinokov / RIA Novosti
The Ministry of Health has registered the drug L-thyroxine, which is taken with a lack of thyroid hormones, produced by the Russian pharmaceutical company Renewal (PFC “Update”), reports TASS with reference to the press service of the department.
“This will allow the company to launch the production of the most important drug for the treatment of thyroid diseases, it is effective in the fight against severe disorders of the endocrine system,” the department explained.
The pharmaceutical company promises that its capacity will allow, if necessary, at the initial stage to reach the volume of 500,000 packs of L-thyroxine per month, and subsequently – 1 million packs. It is planned to launch the production of the drug within a month. The drug will be supplied to the market in two dosages – 50 micrograms and 100 micrograms.
L-thyroxine (international non-proprietary name “levothyroxine sodium”) is a synthetic thyroid hormone preparation included in the list of essential drugs.
Residents reported a shortage of drugs based on L-thyroxine in pharmacies in early March Moscow, Kaliningrad, Tyumen, Petersburg, Sakhalin and other regions.